Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Intramuscular Dexmedetomidine, a Feasible Option for Children With Autism Spectrum Disorders Needing Urgent Procedural Sedation.

Carlone G, Trombetta A, Amoroso S, Poropat F, Barbi E, Cozzi G.

Pediatr Emerg Care. 2019 Feb 19. doi: 10.1097/PEC.0000000000001776. [Epub ahead of print] No abstract available.

PMID:
31268963
2.

Erratum for Rajam et al., "Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States".

Rajam G, Stella M, Kim E, Paulos S, Boccadifuoco G, Serino L, Carlone G, Medini D.

mSphere. 2019 Jun 12;4(3). pii: e00253-19. doi: 10.1128/mSphere.00253-19. No abstract available.

3.

Intramuscular Dexmedetomidine, a Feasible Option for Children With Autism Spectrum Disorders Needing Urgent Procedural Sedation.

Carlone G, Trombetta A, Amoroso S, Poropat F, Barbi E, Cozzi G.

Pediatr Emerg Care. 2019 Jun;35(6):e116-e117. doi: 10.1097/PEC.0000000000001776. No abstract available.

PMID:
31157751
4.

Late effects of total body irradiation on hematopoietic recovery and immune function in rhesus macaques.

Hale LP, Rajam G, Carlone GM, Jiang C, Owzar K, Dugan G, Caudell D, Chao N, Cline JM, Register TC, Sempowski GD.

PLoS One. 2019 Feb 13;14(2):e0210663. doi: 10.1371/journal.pone.0210663. eCollection 2019.

5.

Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens.

Rajam G, Carlone G, Kim E, Choi J, Paulos S, Park S, Jeyachandran A, Gorantla Y, Wong E, Sabnis A, Browning P, Desai R, Quinn CP, Schiffer J.

Biologicals. 2019 Jan;57:9-20. doi: 10.1016/j.biologicals.2018.11.001. Epub 2018 Nov 18.

PMID:
30458978
6.

Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States.

Rajam G, Stella M, Kim E, Paulos S, Boccadifuoco G, Serino L, Carlone G, Medini D.

mSphere. 2017 Nov 15;2(6). pii: e00261-17. doi: 10.1128/mSphere.00261-17. eCollection 2017 Nov-Dec. Erratum in: mSphere. 2019 Jun 12;4(3):.

7.

X-Linked Hypohidrotic Ectodermal Dysplasia: New Features and a Novel EDA Gene Mutation.

Savasta S, Carlone G, Castagnoli R, Chiappe F, Bassanese F, Piras R, Salpietro V, Brazzelli V, Verrotti A, Marseglia GL.

Cytogenet Genome Res. 2017;152(3):111-116. doi: 10.1159/000478922. Epub 2017 Sep 7.

PMID:
28877528
8.

Efficacy of ketogenic diet for infantile spasms: A systematic review.

Prezioso G, Carlone G, Zaccara G, Verrotti A.

Acta Neurol Scand. 2018 Jan;137(1):4-11. doi: 10.1111/ane.12830. Epub 2017 Sep 6. Review.

PMID:
28875525
9.

Follow-up study of idiopathic generalized epilepsy with associated absence seizure and myoclonic epilepsy of infancy.

Belcastro V, Giordano L, Pruna D, Peruzzi C, Casellato S, Barca S, Carlone G, Striano P, Verrotti A.

Epilepsy Res. 2017 Oct;136:123-125. doi: 10.1016/j.eplepsyres.2017.08.001. Epub 2017 Aug 14.

PMID:
28829985
10.

Immune Responses in U.S. Military Personnel Who Received Meningococcal Conjugate Vaccine (MenACWY) Concomitantly with Other Vaccines Were Higher than in Personnel Who Received MenACWY Alone.

Broderick MP, Romero-Steiner S, Rajam G, Johnson SE, Milton A, Kim E, Choi LJ, Radin JM, Schmidt DS, Carlone GM, Messonnier N, Faix DJ.

Clin Vaccine Immunol. 2016 Aug 5;23(8):672-80. doi: 10.1128/CVI.00267-16. Print 2016 Aug.

11.

Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination.

Holme D, Findlow H, Sow SO, Idoko OT, Preziosi MP, Carlone G, Plikaytis BD, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S563-9. doi: 10.1093/cid/civ505.

12.

Human Complement Bactericidal Responses to a Group A Meningococcal Conjugate Vaccine in Africans and Comparison to Responses Measured by 2 Other Group A Immunoassays.

Price GA, Hollander AM, Plikaytis BD, Mocca BT, Carlone G, Findlow H, Borrow R, Sow SO, Diallo A, Idoko OT, Enwere GC, Elie C, Preziosi MP, Kulkarni PS, Bash MC.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S554-62. doi: 10.1093/cid/civ504.

PMID:
26553688
13.

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2-29 Years.

Diallo A, Sow SO, Idoko OT, Hirve S, Findlow H, Preziosi MP, Elie C, Kulkarni PS, Parulekar V, Diarra B, Cheick Haidara F, Diallo F, Tapia M, Akinsola AK, Adegbola RA, Bavdekar A, Juvekar S, Chaumont J, Martellet L, Marchetti E, LaForce MF, Plikaytis BD, Enwere GC, Tang Y, Borrow R, Carlone G, Viviani S.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S521-30. doi: 10.1093/cid/civ518.

14.

Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.

Tapia MD, Findlow H, Idoko OT, Preziosi MP, Kulkarni PS, Enwere GC, Elie C, Parulekar V, Sow SO, Haidara FC, Diallo F, Doumbia M, Akinsola AK, Adegbola RA, Kampmann B, Chaumont J, Martellet L, Marchetti E, Viviani S, Tang Y, Plikaytis BD, LaForce FM, Carlone G, Borrow R.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S514-20. doi: 10.1093/cid/civ672.

15.

A Proteomic Characterization of Bordetella pertussis Clinical Isolates Associated with a California State Pertussis Outbreak.

Williamson YM, Moura H, Whitmon J, Woolfitt AR, Schieltz DM, Rees JC, Guo S, Kirkham H, Bouck D, Ades EW, Tondella ML, Carlone GM, Sampson JS, Barr JR.

Int J Proteomics. 2015;2015:536537. doi: 10.1155/2015/536537. Epub 2015 May 24.

16.

Heterozygous NPR2 Mutations Cause Disproportionate Short Stature, Similar to Léri-Weill Dyschondrosteosis.

Hisado-Oliva A, Garre-Vázquez AI, Santaolalla-Caballero F, Belinchón A, Barreda-Bonis AC, Vasques GA, Ramirez J, Luzuriaga C, Carlone G, González-Casado I, Benito-Sanz S, Jorge AA, Campos-Barros A, Heath KE.

J Clin Endocrinol Metab. 2015 Aug;100(8):E1133-42. doi: 10.1210/jc.2015-1612. Epub 2015 Jun 15.

PMID:
26075495
17.

The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccines.

Idoko OT, Okolo SN, Plikaytis B, Akinsola A, Viviani S, Borrow R, Carlone G, Findlow H, Elie C, Kulkarni PS, Preziosi MP, Ota M, Kampmann B.

Vaccine. 2014 Jul 16;32(33):4220-7. doi: 10.1016/j.vaccine.2014.04.052. Epub 2014 May 23.

PMID:
24863486
18.

Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel.

Patel M, Romero-Steiner S, Broderick MP, Thomas CG, Plikaytis BD, Schmidt DS, Johnson SE, Milton AS, Carlone GM, Clark TA, Messonnier NE, Cohn AC, Faix DJ.

Vaccine. 2014 Jun 24;32(30):3805-9. doi: 10.1016/j.vaccine.2014.05.001. Epub 2014 May 14.

19.

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.

Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B.

Nat Immunol. 2014 Feb;15(2):195-204. doi: 10.1038/ni.2789. Epub 2013 Dec 15.

20.

Absence of high molecular weight proteins 1 and/or 2 is associated with decreased adherence among non-typeable Haemophilus influenzae clinical isolates.

Vuong J, Wang X, Theodore JM, Whitmon J, Gomez de Leon P, Mayer LW, Carlone GM, Romero-Steiner S.

J Med Microbiol. 2013 Nov;62(Pt 11):1649-56. doi: 10.1099/jmm.0.058222-0. Epub 2013 Aug 29.

PMID:
23988628
21.

Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study.

Vierucci F, Del Pistoia M, Fanos M, Gori M, Carlone G, Erba P, Massimetti G, Federico G, Saggese G.

Eur J Pediatr. 2013 Dec;172(12):1607-17.

PMID:
23959324
22.

Immunoactivating peptide p4 augments alveolar macrophage phagocytosis in two diverse human populations.

Bangert M, Wright AK, Rylance J, Kelly MJ, Wright AD, Carlone GM, Sampson JS, Rajam G, Ades EW, Kadioglu A, Gordon SB.

Antimicrob Agents Chemother. 2013 Sep;57(9):4566-9. doi: 10.1128/AAC.00742-13. Epub 2013 Jul 1.

23.

Phenotypic, genomic, and transcriptional characterization of Streptococcus pneumoniae interacting with human pharyngeal cells.

Kimaro Mlacha SZ, Romero-Steiner S, Hotopp JC, Kumar N, Ishmael N, Riley DR, Farooq U, Creasy TH, Tallon LJ, Liu X, Goldsmith CS, Sampson J, Carlone GM, Hollingshead SK, Scott JA, Tettelin H.

BMC Genomics. 2013 Jun 9;14:383. doi: 10.1186/1471-2164-14-383.

24.

Transcriptional adaptation of pneumococci and human pharyngeal cells in the presence of a virus infection.

Kimaro Mlacha SZ, Peret TC, Kumar N, Romero-Steiner S, Dunning Hotopp JC, Ishmael N, Grinblat-Huse V, Riley DR, Erdman DD, Carlone GM, Sampson J, Scott JA, Tettelin H.

BMC Genomics. 2013 Jun 7;14:378. doi: 10.1186/1471-2164-14-378.

25.

Immunogenicity and safety of a new meningococcal A conjugate vaccine in Indian children aged 2-10 years: a phase II/III double-blind randomized controlled trial.

Hirve S, Bavdekar A, Pandit A, Juvekar S, Patil M, Preziosi MP, Tang Y, Marchetti E, Martellet L, Findlow H, Elie C, Parulekar V, Plikaytis B, Borrow R, Carlone G, Kulkarni PS, Goel A, Suresh K, Beri S, Kapre S, Jadhav S, Preaud JM, Viviani S, LaForce FM.

Vaccine. 2012 Oct 5;30(45):6456-60. doi: 10.1016/j.vaccine.2012.08.004. Epub 2012 Aug 13.

PMID:
22898557
26.

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.

Plikaytis BD, Stella M, Boccadifuoco G, DeTora LM, Agnusdei M, Santini L, Brunelli B, Orlandi L, Simmini I, Giuliani M, Ledroit M, Hong E, Taha MK, Ellie K, Rajam G, Carlone GM, Claus H, Vogel U, Borrow R, Findlow J, Gilchrist S, Stefanelli P, Fazio C, Carannante A, Oksnes J, Fritzsønn E, Klem AM, Caugant DA, Abad R, Vázquez JA, Rappuoli R, Pizza M, Donnelly JJ, Medini D.

Clin Vaccine Immunol. 2012 Oct;19(10):1609-17. Epub 2012 Aug 8.

27.

Measurement of Haemophilus influenzae type a capsular polysaccharide antibodies in cord blood sera.

Schmidt DS, Bieging KT, Gomez-de-León P, Villaseñor-Sierra A, Inostroza J, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S.

Pediatr Infect Dis J. 2012 Aug;31(8):876-8. doi: 10.1097/INF.0b013e31825ab166.

28.

A gel-free proteomic-based method for the characterization of Bordetella pertussis clinical isolates.

Williamson YM, Moura H, Simmons K, Whitmon J, Melnick N, Rees J, Woolfitt A, Schieltz DM, Tondella ML, Ades E, Sampson J, Carlone G, Barr JR.

J Microbiol Methods. 2012 Aug;90(2):119-33. doi: 10.1016/j.mimet.2012.04.007. Epub 2012 Apr 18.

29.

A rapid method for capture and identification of immunogenic proteins in Bordetella pertussis enriched membranes fractions: a fast-track strategy applicable to other microorganisms.

West R, Whitmon J, Williamson YM, Moura H, Nelson M, Melnick N, Tondella ML, Schieltz D, Rees J, Woolfitt AR, Barr JR, Ades EW, Carlone GM, Sampson JS.

J Proteomics. 2012 Mar 16;75(6):1966-72. doi: 10.1016/j.jprot.2011.12.034. Epub 2012 Jan 5.

PMID:
22245551
30.

A Novel Innate Immune-Enhancement Strategy Combined with IVIG Rescues Mice from Fatal Staphylococcus aureus Septicemia.

Rajam G, Hammons GM, Carlone GM, Sampson JS, Ades EW.

Int J Microbiol. 2011;2011:725483. doi: 10.1155/2011/725483. Epub 2011 Nov 16.

31.

Establishment of a new human pneumococcal standard reference serum, 007sp.

Goldblatt D, Plikaytis BD, Akkoyunlu M, Antonello J, Ashton L, Blake M, Burton R, Care R, Durant N, Feavers I, Fernsten P, Fievet F, Giardina P, Jansen K, Katz L, Kierstead L, Lee L, Lin J, Maisonneuve J, Nahm MH, Raab J, Romero-Steiner S, Rose C, Schmidt D, Stapleton J, Carlone GM.

Clin Vaccine Immunol. 2011 Oct;18(10):1728-36. doi: 10.1128/CVI.05252-11. Epub 2011 Aug 18.

32.

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, Carlone G, Tapia M, Akinsola AK, Arduin P, Findlow H, Elie C, Haidara FC, Adegbola RA, Diop D, Parulekar V, Chaumont J, Martellet L, Diallo F, Idoko OT, Tang Y, Plikaytis BD, Kulkarni PS, Marchetti E, LaForce FM, Preziosi MP.

N Engl J Med. 2011 Jun 16;364(24):2293-304. doi: 10.1056/NEJMoa1003812.

33.

Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a.

Rouphael NG, Satola S, Farley MM, Rudolph K, Schmidt DS, Gomez-de-León P, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S.

Clin Vaccine Immunol. 2011 Feb;18(2):243-7. doi: 10.1128/CVI.00219-10. Epub 2010 Dec 22.

34.

Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera.

Rose CE, Romero-Steiner S, Burton RL, Carlone GM, Goldblatt D, Nahm MH, Ashton L, Haston M, Ekström N, Haikala R, Käyhty H, Henckaerts I, Durant N, Poolman JT, Fernsten P, Yu X, Hu BT, Jansen KU, Blake M, Simonetti ER, Hermans PW, Plikaytis BD.

Clin Vaccine Immunol. 2011 Jan;18(1):135-42. doi: 10.1128/CVI.00370-10. Epub 2010 Nov 17.

35.

P4 peptide therapy rescues aged mice from fatal pneumococcal sepsis.

Rajam G, Bangert M, Hammons GM, Melnick N, Carlone GM, Sampson JS, Ades EW.

Clin Vaccine Immunol. 2010 Nov;17(11):1823-4. doi: 10.1128/CVI.00366-10. Epub 2010 Sep 15. No abstract available.

36.

Mass spectrometric analysis of multiple pertussis toxins and toxoids.

Williamson YM, Moura H, Schieltz D, Rees J, Woolfitt AR, Pirkle JL, Sampson JS, Tondella ML, Ades E, Carlone G, Barr JR.

J Biomed Biotechnol. 2010;2010:942365. doi: 10.1155/2010/942365. Epub 2010 May 23.

37.

Advances in the development of vaccines against Neisseria meningitidis.

Tan LK, Carlone GM, Borrow R.

N Engl J Med. 2010 Apr 22;362(16):1511-20. doi: 10.1056/NEJMra0906357. Review. No abstract available.

38.

An augmented passive immune therapy to treat fulminant bacterial infections.

Rajam G, Sampson J, Carlone GM, Ades EW.

Recent Pat Antiinfect Drug Discov. 2010 Jun;5(2):157-67. Review.

PMID:
20370679
39.

Interlaboratory comparison of three multiplexed bead-based immunoassays for measuring serum antibodies to pneumococcal polysaccharides.

Whaley MJ, Rose C, Martinez J, Laher G, Sammons DL, Smith JP, Snawder JE, Borrow R, Biagini RE, Plikaytis B, Carlone GM, Romero-Steiner S.

Clin Vaccine Immunol. 2010 May;17(5):862-9. doi: 10.1128/CVI.00022-10. Epub 2010 Mar 24.

40.

Concomitant administration of recombinant PsaA and PCV7 reduces Streptococcus pneumoniae serotype 19A colonization in a murine model.

Whaley MJ, Sampson JS, Johnson SE, Rajam G, Stinson-Parks A, Holder P, Mauro E, Romero-Steiner S, Carlone GM, Ades EW.

Vaccine. 2010 Apr 19;28(18):3071-5. doi: 10.1016/j.vaccine.2010.02.086. Epub 2010 Mar 4.

PMID:
20206671
41.

Revaccination with a 23-valent pneumococcal polysaccharide vaccine induces elevated and persistent functional antibody responses in adults aged 65 > or = years.

Manoff SB, Liss C, Caulfield MJ, Marchese RD, Silber J, Boslego J, Romero-Steiner S, Rajam G, Glass NE, Whitney CG, Carlone GM.

J Infect Dis. 2010 Feb 15;201(4):525-33. doi: 10.1086/651131.

PMID:
20088694
42.

Investigation of different group A immunoassays following one dose of meningococcal group A conjugate vaccine or A/C polysaccharide vaccine in adults.

Findlow H, Plikaytis BD, Aase A, Bash MC, Chadha H, Elie C, Laher G, Martinez J, Herstad T, Newton E, Viviani S, Papaspyridis C, Kulkarni P, Wilding M, Preziosi MP, Marchetti E, Hassan-King M, La Force FM, Carlone G, Borrow R.

Clin Vaccine Immunol. 2009 Jul;16(7):969-77. doi: 10.1128/CVI.00068-09. Epub 2009 May 27.

43.

Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model.

Melnick N, Rajam G, Carlone GM, Sampson JS, Ades EW.

Clin Vaccine Immunol. 2009 Jun;16(6):806-10. doi: 10.1128/CVI.00120-09. Epub 2009 Apr 22. Erratum in: Clin Vaccine Immunol. 2009 Jul;16(7):1093.

44.

A 28-aa pneumococcal surface adhesin A-derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection.

Rajam G, Skinner J, Melnick N, Martinez J, Carlone GM, Sampson JS, Ades EW.

J Infect Dis. 2009 Apr 15;199(8):1233-8. doi: 10.1086/597425.

PMID:
19265478
45.

Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure.

O'Brien KL, Moïsi J, Romero-Steiner S, Holder P, Carlone GM, Reid R, Santosham M.

Vaccine. 2009 Mar 13;27(12):1863-8. doi: 10.1016/j.vaccine.2008.12.060. Epub 2009 Jan 24.

PMID:
19171175
46.

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007.

Tondella ML, Carlone GM, Messonnier N, Quinn CP, Meade BD, Burns DL, Cherry JD, Guiso N, Hewlett EL, Edwards KM, Xing D, Giammanco A, Wirsing von König CH, Han L, Hueston L, Robbins JB, Powell M, Mink CM, Poolman JT, Hildreth SW, Lynn F, Morris A.

Vaccine. 2009 Feb 5;27(6):803-14. doi: 10.1016/j.vaccine.2008.11.072. Epub 2008 Dec 9.

PMID:
19071179
47.

Pneumococcal surface adhesin A (PsaA): a review.

Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW.

Crit Rev Microbiol. 2008;34(3-4):163-73. doi: 10.1080/10408410802383610. Retraction in: Crit Rev Microbiol. 2009 Feb;35(1):67.

PMID:
18819028
48.

Pneumococcal surface adhesin A (PsaA): a review.

Rajam G, Anderton JM, Carlone GM, Sampson JS, Ades EW.

Crit Rev Microbiol. 2008;34(3-4):131-42. doi: 10.1080/10408410802275352 . Review.

PMID:
18728990
49.

Differentiation of Streptococcus pneumoniae conjunctivitis outbreak isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Williamson YM, Moura H, Woolfitt AR, Pirkle JL, Barr JR, Carvalho Mda G, Ades EP, Carlone GM, Sampson JS.

Appl Environ Microbiol. 2008 Oct;74(19):5891-7. doi: 10.1128/AEM.00791-08. Epub 2008 Aug 15.

50.

The different forms of PNS myelin P0 protein within and outside lipid rafts.

Fasano A, Amoresano A, Rossano R, Carlone G, Carpentieri A, Liuzzi GM, Pucci P, Riccio P.

J Neurochem. 2008 Oct;107(1):291-301. doi: 10.1111/j.1471-4159.2008.05598.x. Epub 2008 Aug 1. Erratum in: J Neurochem. 2009 Apr;109(2):682.

Supplemental Content

Loading ...
Support Center